AcouSort and GenSensor collaboration develops according to plan
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
In April 2024, AcouSort AB (“AcouSort”) and GenSensor SAS (“GenSensor”) announced that the two companies will collaborate to combine AcouSort’s acoustofluidics technology with GenSensor’s Biology First Process Analytical Technology to accelerate bioprocess design and improve monitoring systems for bioreactor culturing. GenSensor has now placed its first order for AcouTrap modules to be used for internal product development.
By combining the two companies’ technologies, AcouSort and GenSensor aim to automate cell capture and clean-up prior to molecular analysis. Initially, the collaboration focuses on integration of AcouTrap units with GenSensor’s device as well as development of a new generation of devices dedicated to bioprocess monitoring and additional data collection regarding the isolated samples. In a future commercial phase, AcouSort will provide its AcouTrap units to GenSensor as OEM components.
“I am very pleased that the collaboration with GenSensor develops according to plan. AcouSort and GenSensor share a common interest in providing the healthcare market with innovative solutions that leads to better patient outcomes upon treatment,” says Agnes Michanek, Commercial Director at AcouSort.
ABOUT GENSENSOR
GenSensor was founded with a vision to become a game changer in the field of biology first Process Analytical Technology. The company develops robotic devices and AI algorithms to monitor, characterize and optimize bioproduction of ATMP and vaccines.